Blood samples from patients with long COVID who are still suffering from fatigue and shortness of breath after a year show signs of autoimmune disease, according to a study published today (Thursday) in the European Respiratory Journal [1].
Autoimmune disease occurs when the immune system mistakenly attacks healthy parts of the body, instead of defending the body against disease. It causes conditions such as rheumatoid arthritis and lupus.
Researchers say this finding offers clues about the nature of long COVID that could ultimately lead to improvements in diagnosing and treating the condition.
The research was led by Dr Manali Mukherjee from McMaster University, Ontario, Canada and Professor Chris Carlsten at the University of British Columbia, Vancouver, Canada. Dr Mukherjee said: “Although long COVID is now recognised by bodies like the World Health Organization, we still know very little about why it develops or how we can help patients.
“I’m a respiratory researcher with a background in studying the immune system and when I experienced the symptoms of long COVID first-hand, I began to wonder about the role of the immune system in this condition.”
To find out more, Dr Mukherjee and her colleagues recruited 106 people who had been diagnosed with COVID-19 between August 2020 and September 2021 and were under the care of three hospitals in Canada (St. Joseph’s Healthcare Hamilton, Vancouver General Hospital and St. Paul’s Hospital, Vancouver). Researchers also included a group of 22 healthy volunteers and a group of 34 people who had experienced a non-COVID respiratory infection as a comparison.
On three occasions – three, six and 12 months after they recovered from the infection – patients were asked if they were suffering any shortness of breath, coughing or fatigue (typical symptoms of long COVID). Most patients were still taking part in the study after six months (98 out of 106) while only 57 came back after 12 months. Researchers say this may be due to patients recovering.
Participants also gave blood samples. Researchers tested the samples for particular antibodies. Antibodies are normally produced by the immune system to stick to potentially harmful bacteria or viruses, marking them out for attack by other parts of the immune system. In this case, the researchers looked for antibodies that target healthy cells and tissues in the body and that are known to contribute to autoimmune diseases.
Nearly 80% of the COVID-19 patients had two or more of these antibodies in their blood three months and six months after the infection. This fell to 41% after a year. Most of the healthy volunteers had no sign of these antibodies in their blood and in those who had experienced a non-COVID respiratory infection, levels of these antibodies were comparatively low.
Researchers also found that two specific ‘autoantibodies’ (called U1snRNP and SSb-La autoantibodies), along with other proteins (called cytokines) that cause inflammation, persisted in around 30% of COVID patients a year after infection. This tended to be among those patients who were also still suffering with fatigue and shortness of breath.
Dr Mukherjee explains: “For the majority the patients in our study, even if they had autoantibodies soon after their infection, this resolved after 12 months. However, in some patients, autoantibodies persist, and these patients are more likely to continue suffering with symptoms and to need medical help.
“These results point towards the need to test for signs of autoimmune disease in patients with symptoms of long COVID that last for a year or more.”
Professor Carlsten added: “Our data on autoantibodies in those months following COVID infection buttresses that of other groups and provides strong plausibility for the presentation of long COVID as a systemic disease.”
Dr Mukherjee and her colleagues will now study long COVID patients over a period of two years to see how their levels of autoantibodies change in the longer term.
Dr Eva Polverino from Vall d’Hebron University Hospital, Barcelona, Spain, is Head of the European Respiratory Society’s Respiratory Infections Assembly and was not involved in the research. She said: “Millions of people around the world are suffering with long COVID and that is having an enormous socioeconomic impact. However, there is a lack of evidence on why some people develop the condition and how we can help patients recover.
“We know that certain infections can, in some cases, trigger longer-term autoimmune diseases such as rheumatoid arthritis. This study adds to growing evidence that similar processes may be involved in long COVID. Further work in this area could increase our understanding of long COVID and how best to diagnose and treat the condition.”
News
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
